Purpose: To analyze change in visual acuity (VA), refractive outcomes, corneal compensated intraocular pressure (IOPcc), corneal hysteresis (CH) and cornea resistance factor (CRF) after transepithelial cross-linking (CXL) treatment.
INTRODUCTION
The biomechanical properties of the cornea are primarily determined by the collagen fibers within the storma and degree of interfibrillar linkage. 1 Collagen cross-linking (CXL) in the cornea using ultraviolet A (UVA) light and the photosensitizer riboflavin has been developed recently as a novel method leading to a significant increase in the mechanical stiffness of the cornea, as demonstrated in biomechanical stress-strain measurements. 2, 3 Keratoconus starts at puberty, progressing in approximately 20% to such an extent that penetrating keratoplasty becomes necessary. 4, 5 Wollensak et al 6 reported
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that corneal collagen CXL with UVA and riboflavin leads to a mean of 2.00 diopters (D) of topographic flattening as an alternative management of keratoconus. Increase in biomechanical strength after CXL has been demonstrated by stress-strain measurements, as well as thermal and enzyme digestion studies. Stress-strain studies have been performed in human donor corneas. The change in human donor corneas was a significant increase in elastic modulus. 13 In this study, changes in visual acuity (VA), refraction and specific ocular response analyzer (ORA) values after CXL treatment were analyzed to evaluate visual and biomechancial response to a transepithelial procedure.
MATERIALS AND METHODS
In this retrospective study, 32 eyes of 22 patients (14 males and eight female) with keratoconus were included. Informed consent was obtained from all patients before the CXL procedure.
Uncorrected visual acuity (UCVA; Snellen line), best corrected visual acuity (BCVA; Snellen line), manifest spheric and cylinderic refraction measurements, and keratometric data were obtained before and 3 months following treatment of transepithelial CXL.
On a subset of 14 eyes, measurements were obtained with the ORA, including cornal compensated intraocular pressure (IOPcc), corneal hysteresis (CH) and corneal resistance factor (CRF). In addition, the amplitude of the first peak in the infrared signal (peak 1), corresponding to the first inward applanation event, was recorded. Statistical comparisons of preoperative and postoperative values were performed using the paired two samples test for UCVA, BCVA, pachymetry (CCT), mean K values, IOPcc, CH, CRF and peak 1 value. After treatment artificial tear drop was recommended for 3 days.
Surgical Technique

RESULTS
The mean age of patients was 26.37 ± 8.41 years. Mean UCVA and BCVA significantly improved from 3.04 ± 2.15 and 4.98 ± 2.48 lines preoperative, to 4.80 ± 2.37 and 6.59 ± 2.34 lines (Snellen acuity) postoperative, respectively (p < 0.05) ( Table 1 ). The magnitude of improvements in UCVA and BCVA were 1.76 ± 2.27 lines and 1.61 ± 2.52 Snellen lines.
Preoperative mean spheric, cylinderic refraction and mean K value did not show a significant change from -3.21 ± 3.13, -2.18 ± 1.55 and 47.44 ± 4.95 D to -2.47 ± 2.51, -1.75 ± 1.32 and 46.33 ± 3.62 D, respectively (p > 0.05) ( Table 1) .
Preoperative IOPcc, CRF and CH were 16.58 ± 4.94, 6.67 ± 1.88 and 7.17 ± 2.19 mm Hg and post-CXL values were 15.77 ± 3.14, 6.37 ± 1.39 and 7.07 ± 1.49 mm Hg, respectively, but the differences were not statistically significant (p > 0.05) (Fig. 1) .
However, when the infrared signals were analyzed, preoperative peak 1 signal amplitude increased significantly (p < 0.05) (Figs 2 to 3B).
DISCUSSION
This study has shown that transepithelial CXL treatment appears to be effective in improving VA within 3 months, but statistically significant improvement was not observed in refractive outcomes in the short-term period.
Wollensak et al 6 reported regression with reduction of the maximal keratometry readings by 2.01 D after CXL treatment with removal of epithelium in 70% eyes with a During ORA measurement, a precisely metered air pulse is delivered to the eye, causing the cornea to move inward, past a first applanation and into a slight concavity. The infrared (IR) emitter/detector system records the IR signal during defomation under the air puff, and this signal defines two precise applanation times corresponding to two welldefined peaks in the IR signal produced by inward and outward flattening of the cornea during the applanation events. 12 The amplitude of the first applantion peak in the signal, Peak 1, has been shown to correspond to corneal stiffness with a high peak 1 meaning a stiffer cornea, 15, 16 as illustrated in Figure 4 . After CXL treatment, we observed significantly higher peak 1 signals corresponding to an increase in corneal stiffness, similar to that reported using an epithelium-off approach. 14 This value is different from CH, which is a viscoelastic parameter and responds to changes in stiffness as well as changes in viscosity, 17 both of which are altered in CXL. In the postoperative period, hysteresis was not significantly different, and yet peak 1 signals significantly increased, which show CXL treatment effectivity in terms of stiffness. There is no report about cornea biomechanical properties after CXL treatment with intact epithelium. The concern with not removing epithelium is inadequate penetration of riboflavin, but an important point to remember is that the epithelial layer thickness is not uniform over the entire keratoconic cornea. It is thinner over the cone area, with a thicker annulus around the cone. 18 In addition, the patients are receiving medicine each 2 to 3 minutes by drops which may result in damage to the epithelial junctions allowing easier penetration of riboflavin. Limited penetration may 19 showed increased keratocyte damage with UV light when the epithelium was removed. The study concluded that the epithelium may play significant role in absorbing UVA and thus protecting the cornea and deeper structures from damage.
In this study, we performed transepithelial CXL treatment and observed that there was no correlation between improvement in VA and refractive results. Imrovement in VA was statistically significant although changes in spheric, cylinderic and mean K values were not statistically significant. This significant improvement in visual acuity with nearly same refraction following a short follow-up period may be related to two-factors. The first may be a change in collagen fiber orientation with the collagen fibers becoming more regular as they are crosslinked. The second may be the correction of irregular astigmatism in the central area.
CONCLUSION
Transepithelial CXL makes the cornea stiffer as indicated by an increase in Peak 1, without changing CH and CRF. This is associated with a significant improvement in vision, but not refraction. The stiffer cornea has a wider area of applanation leading to a greater number of photons reflected toward the detector and a greater peak amplitude. The softer cornea has a narrower deformation and applanation area leading to fewer photons aligned with the detector and lower peak amplitudes. CXL treatment provides stiffer cornea and thus an increase in the peak magnitudes
